You posted that Roche is now your favorite company and your uber favorite coronavirus company.
https://www.bloomberg.com/news/articles/2020-...f-patients
But the article you posted says this...
The pharmaceutical company said it’s ramping up production of high-tech machinery needed to use the tool.
What Roche is trying to bring to market, as you well know because of all of your marketplace experience, is traditional clinical chemistry/microbiology. What Roche is increasing in production are COBAS analyzers to read the traditional test method.
DECN is one of the few and in my opinion that has a leg up because they are using an impedance method, the major component and the magic in an existing product, which you and all of the rest of the penny trader cum clinical chemistry mavins know is more useful at being a screening tool and can be completed for commercial viability much quicker.
But this is all a waste of words because the only thing that matters to the penny traders is share price and today's posts prove how apparent that is.
Remember what my friend Barbara Asbell says... salesman should sell, stock traders should trade, message board posters should post, engineers and chemists should make things work, and managers should manage. People around here would be better off taking that advice. All IMO.
https://www.bloomberg.com/news/articles/2020-...f-patients
But the article you posted says this...
The pharmaceutical company said it’s ramping up production of high-tech machinery needed to use the tool.
What Roche is trying to bring to market, as you well know because of all of your marketplace experience, is traditional clinical chemistry/microbiology. What Roche is increasing in production are COBAS analyzers to read the traditional test method.
DECN is one of the few and in my opinion that has a leg up because they are using an impedance method, the major component and the magic in an existing product, which you and all of the rest of the penny trader cum clinical chemistry mavins know is more useful at being a screening tool and can be completed for commercial viability much quicker.
But this is all a waste of words because the only thing that matters to the penny traders is share price and today's posts prove how apparent that is.
Remember what my friend Barbara Asbell says... salesman should sell, stock traders should trade, message board posters should post, engineers and chemists should make things work, and managers should manage. People around here would be better off taking that advice. All IMO.
1
1
